Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

Published:2019-10 Issue:S1 Volume:41 Page:4-18
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Kao Hsiang‐Fong¹²³,Lou Pei‐Jen⁴^ORCID

Affiliation:

1. Department of OncologyNational Taiwan University Hospital Taipei City Taiwan

2. Department of Medical OncologyNational Taiwan University Cancer Center Taipei City Taiwan

3. Institute of Immunology, College of MedicineNational Taiwan University Taipei Taiwan

4. Department of Otolaryngology, National Taiwan University Hospital and College of Medicine Taipei City Taiwan

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25930

Reference91 articles.

1. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018

2. Treating head and neck cancer: for better or for worse?

3. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

4. The blockade of immune checkpoints in cancer immunotherapy

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors;Acta Oto-Laryngologica;2024-08-10

2. Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-08

3. A clinician’s perspective on boron neutron capture therapy: promising advances, ongoing trials, and future outlook;International Journal of Radiation Biology;2024-07-10

4. Dendritic nanoparticles for immune modulation: a potential next-generation nanocarrier for cancer immunotherapy;Nanoscale;2024

5. Endocrine toxicity of immune checkpoint inhibitors: a network meta-analysis of the current evidence;Acta Materia Medica;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3